Picture of Pmv Pharmaceuticals logo

PMVP — Pmv Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapMomentum Trap

PMV Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

* PMV Pharmaceuticals Inc  PMVP.OQ  reported a quarterly
adjusted
loss of 30 cents​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of -42 cents.  The mean expectation of six analysts
for the quarter was for a loss of 36 cents per share. Wall
Street expected results to range from -46 cents to -29 cents per
share.
    * Reported revenue was zero​; analysts expected zero. 
    * PMV Pharmaceuticals Inc's reported EPS for the quarter was
a
loss of 30 cents​.
    * The company reported a quarterly loss of $15.27 million.
    * PMV Pharmaceuticals Inc shares had risen by 27.1% this
quarter and lost 30.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 15% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for PMV
Pharmaceuticals Inc is $6.00 
This summary was machine generated from LSEG data May 9 at 02:38
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.36          -0.30          Beat
 Dec. 31 2023      -0.39          -0.31          Beat
 Sep. 30 2023      -0.45          -0.34          Beat
 Jun. 30 2023      -0.47          -0.38          Beat

Recent news on Pmv Pharmaceuticals

See all news